Viewing Study NCT00002892


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2025-12-27 @ 7:29 PM
Study NCT ID: NCT00002892
Status: COMPLETED
Last Update Posted: 2013-12-19
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
Sponsor: Institute of Cancer Research, United Kingdom
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1995-10
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2001-12
Completion Date Type: ACTUAL
First Submit Date: 1999-11-01
First Submit QC Date: None
Study First Post Date: 2004-05-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-18
Last Update Post Date: 2013-12-19
Last Update Post Date Type: ESTIMATED